DEF: Retractable Technologies, Inc. Announces Annual Meeting of Shareholders, Focus on Director Elections and Executive Compensation

Retractable Technologies, Inc. will hold its 2025 virtual Annual Meeting on May 9, 2025, to vote on the election of three Class 1 Directors, an advisory vote on executive compensation, and an advisory vote on the frequency of executive compensation advisory votes.

Summary

• Retractable Technologies, Inc. is holding its Annual Meeting of Shareholders virtually on May 9, 2025.
• Shareholders will vote on the election of three Class 1 Directors: Marco Laterza, Darren E. Findley, and Amy Mack.
• An advisory vote will be held to approve executive compensation.
• Shareholders will also vote on the frequency of advisory votes on executive compensation, with the Board recommending a vote for every three years.
• The Board of Directors recommends voting 'For All' in the election of Class 1 Directors and 'For' the advisory vote to approve executive compensation.
• The Board recommends voting for 'Every 3 years' on the frequency of executive compensation advisory votes.
• The record date for determining shareholders eligible to vote is March 10, 2025.
• As of March 10, 2025, there were 29,937,159 outstanding shares of Common Stock, excluding treasury shares.
• Thomas J. Shaw, Chairman, President, and CEO, beneficially owns 53.3% of the company's common stock.
• The company's independent accountants are Moss Adams LLP.

Sentiment

Score: 6

Explanation: The document is primarily informational, outlining routine corporate governance matters. While there are some challenges mentioned, the overall tone is neutral.

Positives

• The Board of Directors is actively engaged in corporate governance, with established Audit, Compensation and Benefits, and Nominating Committees.
• The company has a Code of Business Conduct and Ethics in place.
• The Audit Committee is comprised of independent directors.
• The company encourages Board member attendance at Annual Meetings.
• The company has a policy encouraging Board members attendance at Annual Meetings.

Negatives

• One executive officer failed to timely report three trades, though this error was later corrected.
• Executive compensation is not based on specific, quantitative corporate objectives.
• The company acknowledges that its stock price may not adequately reflect its performance.
• Outstanding stock option awards to executive officers were terminated in December 2022 because they were significantly underwater.

Risks

• The company operates in an anticompetitive environment, which may constrain its growth.
• Ongoing litigation is a principal factor influencing the company's operating results.
• The company's ability to grow has been constrained by larger market players.
• The company acknowledges that its stock price may not adequately reflect its performance.

Future Outlook

The company will hold its next executive compensation advisory vote in 2028 if a three-year frequency is deemed appropriate.

Management Comments

• Thomas J. Shaw believes it is in the shareholders best interests for him to serve in the dual role as CEO and Chairman because of his deep knowledge of the strengths and weaknesses of our products and of the Company.
• The Board and its Compensation and Benefits Committee believe the compensation of our named executive officers for 2024 is reasonable and appropriate.
• The Board and its Compensation and Benefits Committee believe that the advisory vote on the frequency of executive compensation votes should be conducted every three years to complement our goal of creating a compensation program that avoids undue emphasis on short-term variations and enhances long-term shareholder value.

Industry Context

The document does not provide specific details on how this announcement relates to broader industry trends or competitors, but it mentions that the company operates in an anticompetitive environment and faces challenges from larger market players.

Comparison to Industry Standards

• The document does not provide specific comparisons to industry standards.
• The document mentions that Longnecker & Associates was engaged in January 2021 to review increases in compensation and option grants to our principal executive officer, principal financial officer, and general counsel.
• Its report presented a market analysis for our three executive officers base salary, annual incentives, and long-term incentives.

Related Party Transactions

• Thomas J. Shaw, President, Chief Executive Officer, and shareholder holding more than 5% of the outstanding Common Stock, contracted with us under the Technology Licensing Agreement for the exclusive worldwide licensing rights to manufacture, market, sell, and distribute retractable medical safety products.
• A royalty of 5% of gross sales of all licensed products sold to customers over the life of the Technology Licensing Agreement is paid.
• Royalties of $3,506,716 and $3,191,276 were paid to Mr. Shaw in 2024 and 2023, respectively.

Stakeholder Impact

• Shareholders have the opportunity to vote on key corporate governance matters.
• Executive compensation decisions impact shareholders and employees.
• The company's performance and strategic direction affect all stakeholders.

Next Steps

• Shareholders are encouraged to vote on the proposals outlined in the proxy statement.
• The company will hold its Annual Meeting on May 9, 2025.
• The Board of Directors will consider the outcome of the advisory votes on executive compensation and the frequency of such votes when making future compensation decisions.

Key Dates

Keywords

proxy statement, annual meeting, executive compensation, directors, corporate governance, shareholders, Retractable Technologies, voting